posted on 2024-07-03, 13:04authored byYu Hsin Tsai, Nathalie B. Milbrandt, Ross Clark Prado, Nicole Beatrice Ponce, Md. Masud Alam, S. Roger Qiu, Xiong Yu, Clemens Burda, Tae Kyong John Kim, Anna Cristina S. Samia
Nanomaterial-mediated antibacterial photodynamic therapy
(aPDT)
emerges as a promising treatment against antibiotic-resistant bacterial
biofilms. Specifically, titanium dioxide nanoparticles (TiO2 NPs) are being investigated as photosensitizers in aPDT to address
biofilm related diseases. To enhance their photocatalytic performance
in the visible spectral range for biomedical applications, various
strategies have been adopted, including reduction of TiO2 NPs. However, despite improvements in visible-light photoactivity,
reduced TiO2 NPs have yet to reach their expected performance
primarily due to the instability of oxygen vacancies and their tendency
to reoxidize easily. To address this, we present a two-step approach
to fabricate highly visible-light active and stable TiO2 NP photocatalysts, involving nitrogen doping followed by a magnesium-assisted
reductive annealing process. X-ray photoelectron spectroscopy analysis
of the synthesized reduced nitrogen-doped TiO2 NPs (H:Mg–N–TiO2 NPs) reveals that the presence of nitrogen stabilizes oxygen
vacancies and reduced Ti species, leading to increased production
of reactive oxygen species under visible-light excitation. The improved
aPDT efficiency translates to a 3-fold enhancement in the antibiofilm
activity of nitrogen-doped compared to undoped reduced TiO2 NPs against both Gram-positive (Streptococcus mutans) and Gram-negative (Porphyromonas gingivalis, Fusobacterium nucleatum) oral pathogens. These results underscore
the potential of H:Mg–N–TiO2 NPs in aPDT
for combating bacterial biofilms effectively.